Literature DB >> 8814279

The primary structure of UK114 tumor antigen.

F Ceciliani1, L Faotto, A Negri, I Colombo, B Berra, A Bartorelli, S Ronchi.   

Abstract

UK114 is a tumor antigen expressed by various malignant neoplasms. The complete amino acid sequence of UK114 purified from goat liver has been determined by automated Edman degradation of CNBr and endoproteinase Lys-C peptides. The protein contains 137 amino acid residues. which corresponds to a molecular mass of 14,229 Da. MALDI-TOF analysis resulted in a molecular weight of 14,290, suggesting that the N-terminal Met residue is acetylated. Sequence comparison shows that UK114 from goat liver (1) has 77% identity with a previously described 23 kDa protein from rat liver (Levy-Favatier et al. (1993) Eur. J. Biochem. 212, 665-673), (2) shares a very high degree of similarity with a family of prokaryotic and eukaryotic hypothetic proteins whose function have not yet been characterized, and (3) exhibits a significant similarity to a group of tumor-associated antigens which belongs to a superfamily of heat shock proteins, acting as possible targets for the host's antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814279     DOI: 10.1016/0014-5793(96)00850-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  A test case for structure-based functional assignment: the 1.2 A crystal structure of the yjgF gene product from Escherichia coli.

Authors:  K Volz
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Crystal structure of Bacillus subtilis YabJ, a purine regulatory protein and member of the highly conserved YjgF family.

Authors:  S Sinha; P Rappu; S C Lange; P Mäntsälä; H Zalkin; J L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Reduced transaminase B (IlvE) activity caused by the lack of yjgF is dependent on the status of threonine deaminase (IlvA) in Salmonella enterica serovar Typhimurium.

Authors:  George Schmitz; Diana M Downs
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

4.  Complex metabolic phenotypes caused by a mutation in yjgF, encoding a member of the highly conserved YER057c/YjgF family of proteins.

Authors:  J L Enos-Berlage; M J Langendorf; D M Downs
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

Review 5.  RidA Proteins Protect against Metabolic Damage by Reactive Intermediates.

Authors:  Jessica L Irons; Kelsey Hodge-Hanson; Diana M Downs
Journal:  Microbiol Mol Biol Rev       Date:  2020-07-15       Impact factor: 11.056

6.  Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells.

Authors:  Latika Dhawan; Bin Liu; Allison Pytlak; Satyarth Kulshrestha; Burns C Blaxall; Mark B Taubman
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

7.  Identification of a perchloric acid-soluble protein (PSP)-like ribonuclease from Trichomonas vaginalis.

Authors:  Alma Villalobos-Osnaya; Georgina Garza-Ramos; Iris N Serratos; César Millán-Pacheco; Arturo González-Robles; Rossana Arroyo; Laura Itzel Quintas-Granados; María Elizbeth Alvarez-Sanchez
Journal:  Parasitol Res       Date:  2018-09-06       Impact factor: 2.289

8.  Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14.

Authors:  F Nicoletti; R Di Marco; P Sacerdote; P Meroni; K Mangano; C Edwards; A Bartorelli; K Bendtzen; A Panerai
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

9.  Recombinant perchloric acid-soluble protein suppresses the immunoglobulin production of human-human hybridoma HB4C5 cells.

Authors:  Hiroaki Kanouchi; Aya Matsuo; Tatsuzo Oka; Hirofumi Tachibana; Koji Yamada
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

10.  DUK114, the Drosophila orthologue of bovine brain calpain activator protein, is a molecular chaperone.

Authors:  Attila Farkas; Gábor Nardai; Peter Csermely; Peter Tompa; Peter Friedrich
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.